Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Forbion European Acquisition Corp.FRBNU · Entity 108709 | Director | December 09, 2021 | December 09, 2021 |
| Replimune Group, Inc.REPL · Entity 4707 | Director | August 20, 2026 | August 24, 2026 |
| enGene Therapeutics Inc.ENGN · Entity 6638 | Director | June 16, 2026 | June 17, 2026 |
| uniQure N.V.QURE · Entity 4162 | Director | March 02, 2021 | March 04, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Forbion European Acquisition Corp.
Report date December 09, 2021 · Filed December 09, 2021
This filing explicitly reported no securities owned.
Replimune Group, Inc.
Report date August 20, 2026 · Filed August 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,362,414 |
Reported balance
After 2026-08-20 transaction · row 1
1 source rowRow 1 · 2026-08-20 · Gift · Disposed 50,000 · Balance 1,362,414 F1: Represents a bona fide gift of 50,000 shares from the reporting person to a donor-advised fund. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a bona fide gift of 50,000 shares from the reporting person to a donor-advised fund.
enGene Therapeutics Inc.
Report date June 16, 2026 · Filed June 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.75 · Expires 2036-06-16 | Direct | 31,000 |
Reported balance
After 2026-06-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 31,000 · Balance 31,000 F1: This option vests fully on the earlier of (i) the first anniversary of the vesting commencement date, which was June 9, 2026 or (ii) the registrant's 2027 annual meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: This option vests fully on the earlier of (i) the first anniversary of the vesting commencement date, which was June 9, 2026 or (ii) the registrant's 2027 annual meeting of shareholders.
uniQure N.V.
Report date March 02, 2021 · Filed March 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 9,946 |
Reported balance
After 2021-03-02 transaction · row 1
1 source rowRow 1 · 2021-03-02 · Sale · Disposed 504 · Balance 9,946 F1: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.76 to $37.61. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.76 to $37.61. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2019 Filed Aug 5, 2019 16:21 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 866 | $58.15 | $50,357.90 |
DisclosureSEC source: 0000904454-19-000590 · edgar.xml · nonDerivative · entry 1 Astley-Sparke Philip · CIK 0001376491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,406 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.84 to $58.75. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 18:07 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 599 | $64.53 | $38,653.47 |
DisclosureSEC source: 0000904454-19-000460 · edgar.xml · nonDerivative · entry 4 Astley-Sparke Philip · CIK 0001376491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,272 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.40 to $64.69. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 18:07 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 4,401 | $63.80 | $280,783.80 |
DisclosureSEC source: 0000904454-19-000460 · edgar.xml · nonDerivative · entry 3 Astley-Sparke Philip · CIK 0001376491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,871 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.36 to $64.28. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 18:07 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 600 | $62.97 | $37,782.00 |
DisclosureSEC source: 0000904454-19-000460 · edgar.xml · nonDerivative · entry 2 Astley-Sparke Philip · CIK 0001376491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,272 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.35 to $63.28. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 18:07 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 400 | $61.40 | $24,560.00 |
DisclosureSEC source: 0000904454-19-000460 · edgar.xml · nonDerivative · entry 1 Astley-Sparke Philip · CIK 0001376491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,872 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.01 to $61.85. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:23 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantEmployee Stock Option (right to buy) · Derivative | 153,050 | $0.00 Strike: $15.50 | $0.00 |
DisclosureSEC source: 0001104659-19-019707 · a4.xml · derivative · entry 1 Astley-Sparke Philip · CIK 0001376491 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,050 Underlying: Common Stock · 153,050 shares Expires 2029-04-01 F1 · derivative.exercise_date: 25% of the shares underlying this stock option vest on April 1, 2020, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 16:22 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 6,000 | $59.84 | $359,040.00 |
DisclosureSEC source: 0000904454-19-000342 · edgar.xml · nonDerivative · entry 1 Astley-Sparke Philip · CIK 0001376491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,272 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.39 to $60.14. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 22:20 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 1,210 | $31.32 | $37,897.20 |
DisclosureSEC source: 0000904454-19-000128 · edgar.xml · nonDerivative · entry 1 Astley-Sparke Philip · CIK 0001376491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,272 F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.26 to $31.55. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 23:48 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 5,295 | $0.00 Strike: $31.71 | $0.00 |
DisclosureSEC source: 0000904454-19-000092 · edgar.xml · derivative · entry 2 Astley-Sparke Philip · CIK 0001376491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,295 Underlying: Ordinary Shares · 5,295 shares Expires 2029-01-25 F2 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 23:48 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 3,230 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-19-000092 · edgar.xml · nonDerivative · entry 1 Astley-Sparke Philip · CIK 0001376491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,482 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 14:38 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 5,000 | $30.39 | $151,950.00 |
DisclosureSEC source: 0000904454-18-000777 · edgar.xml · nonDerivative · entry 1 Astley-Sparke Philip · CIK 0001376491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,252 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.08 to $30.77. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 21:25 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantEmployee Stock Option (right to buy) · Derivative | 140,000 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001104659-18-047459 · a4.xml · derivative · entry 1 Astley-Sparke Philip · CIK 0001376491 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2028-07-19 F1 · derivative.exercise_date: This option was granted on July 19, 2018 subject to the completion of the Issuer's initial public offering, which closed on July 24, 2018. 25% of the shares underlying this stock option vest on July 19, 2019 and the remainder of the shares underlying this stock option vest in 36 equal monthly installments thereafter. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 15:39 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 6,540 | $18.53 | $121,186.20 |
DisclosureSEC source: 0000904454-18-000091 · edgar.xml · nonDerivative · entry 1 Astley-Sparke Philip · CIK 0001376491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,252 F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.41 to $18.69. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 15:21 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 6,390 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0000904454-18-000056 · edgar.xml · derivative · entry 2 Astley-Sparke Philip · CIK 0001376491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,390 Underlying: Ordinary Shares · 6,390 shares Expires 2028-01-26 F3 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 15:21 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 4,792 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-18-000056 · edgar.xml · nonDerivative · entry 1 Astley-Sparke Philip · CIK 0001376491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,792 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. F2 · balance_after: Includes (i) 5,000 restricted share units that vested in full on January 27, 2017 previously disclosed by the Reporting Person in Table II and (ii) 25,000 restricted share units that vested in full on January 27, 2018 previously disclosed by the Reporting Person in Table II. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 19:56 UTC | uniQure N.V. QURE · Entity 4162 | GrantRestricted Stock Units · Derivative | 25,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-003695 · doc1.xml · derivative · entry 2 Astley-Sparke Philip · CIK 0001376491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 25,000 shares Expires not disclosed F2 · derivative.exercise_date: The Restricted Stock Unit vests 100% on January 27, 2018. F3 · derivative.expiration_date: Expiration date is not applicable as the vested Restricted Stock Units shall be settled on the first business day following the date that such Restricted Stock Units vests. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 19:56 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $5.37 | $0.00 |
DisclosureSEC source: 0001140361-17-003695 · doc1.xml · derivative · entry 1 Astley-Sparke Philip · CIK 0001376491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2027-01-27 F1 · derivative.exercise_date: The Stock Option vests 100% on January 27, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.